CONGRESS COVERAGE: EHA 2020 – FOCUS ON NHL/CLL

Explore the latest therapeutic developments and translational research in NHL and CLL treatment, advances in dynamic and oftentimes individualized clinical decision-making, and how emerging data will affect ongoing research, development of new compounds, and future treatment paradigms

June 16, 2020
Franck Morschhauser, MD, PhD Aptitude Health NHL CLL

FACULTY CO-CHAIR

Franck Morschhauser, MD, PhD

Centre Hospitalier Universitaire de Lille Lille, France

Thomas E. Witzig, MD Aptitude Health NHL CLL

FACULTY CO-CHAIR

Thomas Witzig, MD

Mayo Clinic Rochester, MN, USA

Faculty Members

Stephen M. Ansell, MD, PhD
Mayo Clinic, Rochester, MN

Barbara Eichhorst, MD
University of Munich, Munich, Germany

Raul Cordoba, MD, PhD
Fundacion Jimenez Diaz University Hospital, Madrid, Spain

Mathias Rummel, MD, PhD
Justus-Liebig University-Hospital,
Giessen, Germany

Pier Luigi Zinzani, MD, PhD
University of Bologna, Bologna, Italy

REPORT TOPICS INCLUDE

  • Updates on DLBCL
  • Updates on FL and MCL
  • Updates on T-Cell Lymphoma
  • Updates on CLL
  • Strategic Insights and Key Takeaways

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.